Psychemedics

Psychemedics P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Psychemedics (PMDI) as of Oct 20, 2026 is 10.17. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -5.23 — a change of -294.42% (higher).

P/FCF

10.17

YoY

-294.42%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Psychemedics is 2024 10.17 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Psychemedics was 2023 -5.23 . It decreases by -294.42% higher compared to the previous year.

The Psychemedics P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2017
1.08 USD
Jan 1, 2018
1.27 USD
Jan 1, 2019
3.26 USD
Jan 1, 2020
-1.69 USD
Jan 1, 2021
36.93 USD
Jan 1, 2022
1.82 USD
Jan 1, 2023
-5.23 USD
Jan 1, 2024
10.17 USD
The Psychemedics P/FCF history
YEARP/FCFYoY
10.17-294.42%
-5.23-387.29%
1.82-95.07%
36.93-2,287.07%
-1.69-151.83%
3.26+156.27%
1.27+17.95%
1.08-8.68%
1.18-61.02%
3.03-209.54%
-2.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp provides drug testing services analyzing hair samples for drug presence, offering historical usage patterns and approximate drug intake levels. The company charges customers a per-unit fee for each tested sample, including training for sample collection and storage of positive results. Their primary service targets clients needing drug testing solutions, particularly in sectors requiring regular monitoring of substance use. The firm's technology focuses on hair analysis to deliver detailed insights into drug consumption over time. Psychemedics Corp's revenue model is based on per-unit testing fees, with services including sample collection training and storage of positive samples. Customers pay for each sample tested, leveraging the company's hair analysis technology to monitor drug use patterns. The business operates within the drug testing services segment, serving clients who require reliable and historical data on substance abuse. The company's drug testing services are designed for customers seeking detailed historical data on drug use, with results indicating both the amount ingested and usage patterns over time. Psychemedics Corp generates income through fixed fees per sample tested, covering the full service including sample collection training and positive sample storage. Their focus remains on delivering accurate, long-term drug usage insights through hair analysis. Psychemedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psychemedics stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Psychemedics is 10.17 in 2024.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Psychemedics changed from -5.23 to 10.17, representing a -294.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Psychemedics since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Psychemedics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Psychemedics

All Key Metrics — Psychemedics